Literature DB >> 23797787

How to interpret a randomized controlled study stopped early.

G Leandro1.   

Abstract

Mesh：

Year:  2013        PMID： 23797787     DOI： 10.1007/s00134-013-3000-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  8 in total

1.  Bias and trials stopped early for benefit.

Authors:  Scott M Berry; Bradley P Carlin; Jason Connor
Journal:  JAMA       Date:  2010-07-14       Impact factor: 56.272

Review 2.  Randomized trials stopped early for benefit: a systematic review.

Authors:  Victor M Montori; P J Devereaux; Neill K J Adhikari; Karen E A Burns; Christoph H Eggert; Matthias Briel; Christina Lacchetti; Teresa W Leung; Elizabeth Darling; Dianne M Bryant; Heiner C Bucher; Holger J Schünemann; Maureen O Meade; Deborah J Cook; Patricia J Erwin; Amit Sood; Richa Sood; Benjamin Lo; Carly A Thompson; Qi Zhou; Edward Mills; Gordon H Guyatt
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

Review 3.  Futility approaches to interim monitoring by data monitoring committees.

Authors:  David L Demets
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

4.  Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.

Authors:  Edward L Korn; Boris Freidlin; Margaret Mooney
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

5.  Early stopping for benefit in National Cancer Institute-sponsored randomized Phase III trials: the system is working.

Authors:  Daniel Sargent
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

6.  Stopping clinical trials early for benefit: impact on estimation.

Authors:  Boris Freidlin; Edward L Korn
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

7.  The futility index. An approach to the cost-effective termination of randomized clinical trials.

Authors:  J H Ware; J E Muller; E Braunwald
Journal:  Am J Med       Date:  1985-04       Impact factor: 4.965

8.  High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial.

Authors:  Olivier Joannes-Boyau; Patrick M Honoré; Paul Perez; Sean M Bagshaw; Hubert Grand; Jean-Luc Canivet; Antoine Dewitte; Claire Flamens; Wilfried Pujol; Anne-Sophie Grandoulier; Catherine Fleureau; Rita Jacobs; Christophe Broux; Hervé Floch; Olivier Branchard; Stephane Franck; Hadrien Rozé; Vincent Collin; Willem Boer; Joachim Calderon; Bernard Gauche; Herbert D Spapen; Gérard Janvier; Alexandre Ouattara
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440
  8 in total
  1 in total

Review 1.  High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis.

Authors:  Edward Clark; Amber O Molnar; Olivier Joannes-Boyau; Patrick M Honoré; Lindsey Sikora; Sean M Bagshaw
Journal:  Crit Care       Date:  2014-01-08       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.